Selected Reads

Smartkarma

Equity Bottom-Up

Neo Performance Materials This short post is dedicated to an interesting opportunity opening up recently in NPM – a Canada headquartered advanced industrial materials manufacturer. NPM is one of the global leaders...<a target="_blank" href="https://www.valueinvestorsclub.com/idea/Neo_Performance_Materials_Inc/9524006431">Read the article on Value Investor Club »</a>

United States

NeoGenomics, Inc. operates a network of clinical laboratories that specializes in cancer genetics diagnostic testing services. The Company's services include cytogenetics, fluorescence in-situhybridization (FISH), flow cytometry, morphology, anatomic pathology, and molecular genetic testing. NeoGenomics serves pathologists, oncologists, urologists, and hospitals.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00